Pharming Group's legacy product RUCONEST posted a 10% year-over-year sales decline in Q2 2026 -- and PHAR shares fell 22% the day it was reported. Levi & Korsinsky is investigating potential securities law violations on behalf of PHAR shareholders. NEW YORK, July 31, 2026 /PRNewswire/ --...
Hence then, the article about pharming group investigation notice levi korsinsky notifies investors of pending investigation into pharming group phar was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR) )
Also on site :
- Kenya confirms first Ebola case after patient dies
- Taylor Swift Shatters All-Time Billboard Record as ‘Patient Zero’ Leads 4 New Songs Into Global Top 10
- Croatia Face Spain Today: Kickoff Time and Broadcast Details